FAMOTIDINE TEVA 40 MG

Land: Israël

Taal: Engels

Bron: Ministry of Health

Koop het nu

Download Bijsluiter (PIL)
26-10-2016

Werkstoffen:

FAMOTIDINE

Beschikbaar vanaf:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

ATC-code:

A02BA03

farmaceutische vorm:

TABLETS

Samenstelling:

FAMOTIDINE 40 MG

Toedieningsweg:

PER OS

Prescription-type:

Required

Geproduceerd door:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Therapeutische categorie:

FAMOTIDINE

Therapeutisch gebied:

FAMOTIDINE

therapeutische indicaties:

Treatment of Duodenal Ulcer, Benign Gastric Ulcer, Pathological hypersecretory conditions such as Zollinger-ellison syndrome, Gastroesophageal reflux disease. Prevention of relapses of duodenal ulceration.

Autorisatie datum:

2013-06-30

Bijsluiter

                                PATIENT PACKAGE INSERT IN ACCORDANCE
WITH THE PHARMACISTS’ REGULATIONS
(PREPARATIONS) - 1986
This medicine is dispensed
with a doctor’s prescription only
FAMOTIDINE TEVA
® 40 MG
TABLETS
The active ingredient and its quantity:
Each tablet contains:
Famotidine 40 mg
For a list of the inactive ingredients, please see
Section 6.
READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE
USING THIS MEDICINE. This leaflet contains concise
information about the medicine. If you have further
questions, refer to the doctor or pharmacist.
This medicine has been prescribed for the treatment
of your ailment. Do not pass this medicine on to
others. It may harm them even if it seems to you
that their medical condition is similar.
The medicine is not intended for use in children
below 12 years of age; below this age, refer to the
doctor. The safety of using this medicine in children
has not yet been established. You must use the
medicine correctly. Consult the pharmacist if you
need further information.
1.
WHAT IS THE MEDICINE INTENDED FOR?
• The medicine is intended for treatment of
conditions in which reduced secretion of gastric
juices is required, including treatment of a gastric
or duodenal ulcer, gastroesophageal reflux
disease and Zollinger-Ellison syndrome.
THERAPEUTIC GROUP:
• Inhibitors of gastric acid secretion of the
histamine 2 antagonists group.
2.
BEFORE USING THE MEDICINE: DO NOT USE THIS PREPARATION IF:
• you are breastfeeding.
• you are sensitive to famotidine or to any of
the other ingredients of the medicine or to
other medicines from this group (cimetidine,
ranitidine or nizatidine). BEFORE TREATMENT WITH FAMOTIDINE TEVA
®
, TELL
THE DOCTOR IF:
• you are suffering or have suffered in the past from
impaired liver function.
• you are suffering or have suffered in the past
from a kidney disease or from an impairment of
the urinary tract.
• you are sensitive to any food, medicine or to
ingredients such as preservatives and food
coloring. IF YOU ARE TAKING, OR HAVE RECENTLY TAKEN, OTHER
MEDICINES, IN
                                
                                Lees het volledige document
                                
                            

Documenten in andere talen

Bijsluiter Bijsluiter Hebreeuws 26-10-2016

Zoekwaarschuwingen met betrekking tot dit product

Bekijk de geschiedenis van documenten